Skip to content

CapEx at other companies

Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$769K+0.4%
AbbVie logo
AbbVieABBV
$265M+12.8%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$0-100%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$2.23M-27.2%
Sana Biotechnology logo
Sana BiotechnologySANA
$288K+112%
Jade Biosciences, Inc. Common Stock logo
Jade Biosciences, Inc. Common StockJBIO
$3K

Other financials

Income statement

See full
Revenue$3.0B+7.8%
Gross profit$2.6B+7.8%
Operating income$1.1B+80.6%
Net income$1.0B+59.6%
EPS (diluted)$4.02+61.4%

Balance sheet

See full
Cash & equivalents$5.5B+17.5%
Total debt$2.0B+20.5%
Total equity$19.4B+17.4%
Total assets$26.5B+15.8%

Cash flow

See full
Operating cash flow$1.4B+74.4%
Free cash flow$1.3B+66.4%

Valuation

See full
Market cap$121.87B+7.6%
Enterprise value$118.35B+7.4%
P/E28.1×
P/S10×-0.2×

Profitability

See full
Gross margin86.2%+0.2pp
Operating margin38.3%
Net margin35.5%
FCF margin30.4%+20.2pp

Returns & leverage

See full
Return on equity24.2%
Debt / equity0.1×0.0×
Current ratio+0.4×

Where this comes from

Reported directly by Vertex Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Vertex Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vertex Pharmaceuticals's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vertex Pharmaceuticals's capex?
Vertex Pharmaceuticals (VRTX) reported capex of $133.4M in Q1 2026.
How has Vertex Pharmaceuticals's capex changed year-over-year?
Vertex Pharmaceuticals's capex increased by 227.8% year-over-year, from $40.7M to $133.4M.
What is the long-term trend for Vertex Pharmaceuticals's capex?
Over 4 years (2021 to 2025), Vertex Pharmaceuticals's capex has grown at a 16.8% compound annual growth rate (CAGR), from $235M to $437.6M.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.